Futterman, Sirotkin & Seinfeld, LLP Aggressive | Experienced | Knowledgeable | A Full Service Law Firm
Free Consultations *
For Personal Injury and Medical Malpractice Matters Only
toll free: 866-679-2513
Kew Gardens: 718-577-2573
Woodbury: 516-681-0250
New York: 212-223-2767
Main Menu

Thank you so much for all your help. You are a true God send and I feel blessed for having your assistance. Wishing you and your family well wishes and a Happy New Year too!

Thank you for “services rendered” to my complete satisfaction. On that note, a special thank you to Judy Ramirez and Veronica Fuentes for their many contributions. With your knowledge and experience...

Thank you for doing such a great job representing my son on the purchase of his condo. As I am sure you could tell, he was very nervous about the whole thing, been waiting for the other shoe to...

On behalf of the family of the Estate of Marlene U., I would like to express my sincere gratitude to the law firm of Futterman, Sirotkin & Seinfeld, LLP for its unwavering commitment...

I feel blessed that somehow your firm in and my life crossed because the result is the quality of my mother’s life in respect to current and future needs is secure …

Dear Martin and Ira, thank you so much for working so hard on my case for so many years. My life changed 10 years ago when this occurred. I'm glad this chapter of my life has closed.

Just wanted to express how happy I am with your firm. I have known you for over 15 years starting with the purchase of my first home and when I continued utilizing your services when...

Words can not fully express how grateful and impressed I am with your outstanding services. Working with you and your staff not only made me feel comfortable and reassured but ...

I wanted to express my sincere gratitude for your efforts over the last two years regarding my case. Your attention to the details surrounding-my case was second to none...

Me sentir bien comoda con mi dos abogados, el Sr. Martin y el Sr. Futterman, que me trataron mi caso con mucha delicadeza y puecieron mucho tiempo en mi case

Read More Testimonials
Practice Areas Menu

Study: Breast biopsies often misinterpreted

Every year, it is estimated that about 1.6 million women undergo a breast biopsy in the United States, according to The New York Times. However, a new study shows that pathologists may not be reading the results of these biopsies correctly. This can put women in New York and elsewhere at risk of receiving the wrong type of treatment or no treatment at all.

The study involved eight states, 115 pathologists and an additional panel consisting of three pathologists who were considered experts in the field of breast pathology. Over a seven-year period, the study examined 240 biopsy slides with the purpose of comparing the findings of the panel against those of the other pathologists.

When the results were compiled and examined, 13 percent of the slides were incorrectly identified as abnormal when they were actually normal. More concerning, was the discrepancies found in slides which crossed into a gray area of diagnosis. These included situations where abnormal cells had formed within the breast’s milk duct, CBS Boston explains. The state pathologists misdiagnosed 16 percent of these slides containing this type of cell, a condition known as DCIS. Pathologists diagnosed 3 percent of the slides as showing invasive cancer and 13 percent of the other slides as showing a less serious condition when the expert panel determined the opposite.

The results were even worse when it came to diagnosing a condition known as atypia. This is a condition where abnormal cells are found in the ducts of the breast and is treated through the administration of prescription drugs and even surgery to lower a woman’s risk of developing cancer. In these slides, the correct diagnosis rate was less than 50 percent. The study suggests that in these types of situations, patients would be better off seeking a second opinion.

No Comments

Leave a comment
Comment Information

Privacy Policy | Law Firm Marketing by FindLaw, a Thomson Reuters business.